171 related articles for article (PubMed ID: 34593893)
1. Defined D-hexapeptides bind CUG repeats and rescue phenotypes of myotonic dystrophy myotubes in a Drosophila model of the disease.
Rapisarda A; Bargiela A; Llamusi B; Pont I; Estrada-Tejedor R; Garcia-España E; Artero R; Perez-Alonso M
Sci Rep; 2021 Sep; 11(1):19417. PubMed ID: 34593893
[TBL] [Abstract][Full Text] [Related]
2. In vivo discovery of a peptide that prevents CUG-RNA hairpin formation and reverses RNA toxicity in myotonic dystrophy models.
García-López A; Llamusí B; Orzáez M; Pérez-Payá E; Artero RD
Proc Natl Acad Sci U S A; 2011 Jul; 108(29):11866-71. PubMed ID: 21730182
[TBL] [Abstract][Full Text] [Related]
3. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
[TBL] [Abstract][Full Text] [Related]
4. Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms.
Jenquin JR; Coonrod LA; Silverglate QA; Pellitier NA; Hale MA; Xia G; Nakamori M; Berglund JA
ACS Chem Biol; 2018 Sep; 13(9):2708-2718. PubMed ID: 30118588
[TBL] [Abstract][Full Text] [Related]
5. Muscleblind, BSF and TBPH are mislocalized in the muscle sarcomere of a Drosophila myotonic dystrophy model.
Llamusi B; Bargiela A; Fernandez-Costa JM; Garcia-Lopez A; Klima R; Feiguin F; Artero R
Dis Model Mech; 2013 Jan; 6(1):184-96. PubMed ID: 23118342
[TBL] [Abstract][Full Text] [Related]
6. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
[TBL] [Abstract][Full Text] [Related]
7. Expanded CUG repeats Dysregulate RNA splicing by altering the stoichiometry of the muscleblind 1 complex.
Paul S; Dansithong W; Jog SP; Holt I; Mittal S; Brook JD; Morris GE; Comai L; Reddy S
J Biol Chem; 2011 Nov; 286(44):38427-38438. PubMed ID: 21900255
[TBL] [Abstract][Full Text] [Related]
8. Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy.
Timchenko LT; Timchenko NA; Caskey CT; Roberts R
Hum Mol Genet; 1996 Jan; 5(1):115-21. PubMed ID: 8789448
[TBL] [Abstract][Full Text] [Related]
9. rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences.
Sellier C; Cerro-Herreros E; Blatter M; Freyermuth F; Gaucherot A; Ruffenach F; Sarkar P; Puymirat J; Udd B; Day JW; Meola G; Bassez G; Fujimura H; Takahashi MP; Schoser B; Furling D; Artero R; Allain FHT; Llamusi B; Charlet-Berguerand N
Nat Commun; 2018 May; 9(1):2009. PubMed ID: 29789616
[TBL] [Abstract][Full Text] [Related]
10. In silico discovery of substituted pyrido[2,3-d]pyrimidines and pentamidine-like compounds with biological activity in myotonic dystrophy models.
González ÀL; Konieczny P; Llamusi B; Delgado-Pinar E; Borrell JI; Teixidó J; García-España E; Pérez-Alonso M; Estrada-Tejedor R; Artero R
PLoS One; 2017; 12(6):e0178931. PubMed ID: 28582438
[TBL] [Abstract][Full Text] [Related]
11. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
[TBL] [Abstract][Full Text] [Related]
12. Derepressing muscleblind expression by miRNA sponges ameliorates myotonic dystrophy-like phenotypes in Drosophila.
Cerro-Herreros E; Fernandez-Costa JM; Sabater-Arcis M; Llamusi B; Artero R
Sci Rep; 2016 Nov; 6():36230. PubMed ID: 27805016
[TBL] [Abstract][Full Text] [Related]
13. Genetic and chemical modifiers of a CUG toxicity model in Drosophila.
Garcia-Lopez A; Monferrer L; Garcia-Alcover I; Vicente-Crespo M; Alvarez-Abril MC; Artero RD
PLoS One; 2008 Feb; 3(2):e1595. PubMed ID: 18270582
[TBL] [Abstract][Full Text] [Related]
14. Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.
Wojtkowiak-Szlachcic A; Taylor K; Stepniak-Konieczna E; Sznajder LJ; Mykowska A; Sroka J; Thornton CA; Sobczak K
Nucleic Acids Res; 2015 Mar; 43(6):3318-31. PubMed ID: 25753670
[TBL] [Abstract][Full Text] [Related]
15. A flow cytometry-based screen identifies MBNL1 modulators that rescue splicing defects in myotonic dystrophy type I.
Zhang F; Bodycombe NE; Haskell KM; Sun YL; Wang ET; Morris CA; Jones LH; Wood LD; Pletcher MT
Hum Mol Genet; 2017 Aug; 26(16):3056-3068. PubMed ID: 28535287
[TBL] [Abstract][Full Text] [Related]
16. Rationally designed small molecules that target both the DNA and RNA causing myotonic dystrophy type 1.
Nguyen L; Luu LM; Peng S; Serrano JF; Chan HY; Zimmerman SC
J Am Chem Soc; 2015 Nov; 137(44):14180-9. PubMed ID: 26473464
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features.
Dansithong W; Wolf CM; Sarkar P; Paul S; Chiang A; Holt I; Morris GE; Branco D; Sherwood MC; Comai L; Berul CI; Reddy S
PLoS One; 2008; 3(12):e3968. PubMed ID: 19092997
[TBL] [Abstract][Full Text] [Related]
18. Small molecule kinase inhibitors alleviate different molecular features of myotonic dystrophy type 1.
Wojciechowska M; Taylor K; Sobczak K; Napierala M; Krzyzosiak WJ
RNA Biol; 2014; 11(6):742-54. PubMed ID: 24824895
[TBL] [Abstract][Full Text] [Related]
19. Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1).
Gareiss PC; Sobczak K; McNaughton BR; Palde PB; Thornton CA; Miller BL
J Am Chem Soc; 2008 Dec; 130(48):16254-61. PubMed ID: 18998634
[TBL] [Abstract][Full Text] [Related]
20. Reduced cytoplasmic MBNL1 is an early event in a brain-specific mouse model of myotonic dystrophy.
Wang PY; Lin YM; Wang LH; Kuo TY; Cheng SJ; Wang GS
Hum Mol Genet; 2017 Jun; 26(12):2247-2257. PubMed ID: 28369378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
